Evidence map›Paper›PMID 42776749›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Marangoni-overriding flow in laser-irradiated particle-capped droplets.

Xianglong Pang, Xiaoguang Li

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xianglong PangSchool of Physical Science and Technology, Shaanxi Basic Discipline (Liquid Physics) Research Center, Northwestern Polytechnical University, Xi'an 710129, China.ORCID 0000-0002-7921-1147
Xiaoguang LiSchool of Physical Science and Technology, Shaanxi Basic Discipline (Liquid Physics) Research Center, Northwestern Polytechnical University, Xi'an 710129, China.ORCID 0000-0002-2085-1860

Funding

MOST | National Natural Science Foundation of China (NSFC) 11974280MOST | National Natural Science Foundation of China (NSFC) 52473323
6 · The paper itself

Abstract

When a surface tension gradient exists, a Marangoni flow typically occurs from regions of lower to higher surface tension. Here, we report an overriding of this flow in laser-irradiated droplets capped with a jammed particle layer, where particles migrate along the interface toward the apex of reduced surface tension, against the thermal gradient, via a propagating unjamming front. Initial jamming immobilizes light-absorbing particles at the apex, enabling photothermal energy accumulation therein; this removes the central particles and triggers local, intense evaporation that flattens the apex. This flattening steepens the curvature gradient across the unjammed region, amplifying the centripetal Laplace pressure gradient, which dominates over the opposing hydrostatic and Marangoni stresses to drive centripetal transport-a regime we term Marangoni-overriding flow. This flow continually delivers fresh particles to the apex, sustaining the localized energy absorption and thus the intense evaporation that maintains a nonequilibrium curvature field, thereby keeping the Laplace pressure gradient active. This flow regime recasts interfacial jamming as an active control mechanism and, with its tunability via laser power, droplet size, and fluid viscosity, opens avenues for optofluidics, targeted delivery, and nonequilibrium interface engineering.

Indexed as

interfacial jammingLaplace pressurelaser-driven transportmarangoni-overriding flownonequilibrium interfaces

Identifiers

PMID42776749
PMCPMC13624651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.